ONLINE REGISTRATION IS NOW CLOSED
YOU ARE WELCOME TO REGISTER AT THE EVENT
Monday May 12, 2014
Knowledge-Based CE Session for
Pharmacists and Technicians
Rotunda Room @ The Crowne Plaza, Warwick RI
2014 RI Law Update
“Patient, Professional and Political Advocacy…Provider Status and Compounding Legislation”
and ASHP Update
2 CEU Credits
ACPE# 0132-0000-14-003-L03-P
ACPE# 0132-0000-14-003-L03-T
Program Agenda
4:45 Registration
5:30 Dinner
5:45-6:45 Presentation
6:45 Dessert
7:00-8:00 Presentation
Members $25
Non- Members $50
Law Update:
Patient, Professional and Political Advocacy…
Provider Status and Compounding Legislation
Linda A. Nelson, BS, PharmD, Clinical Pharmacy Specialist,
Women & Infants Hospital of Rhode Island
Ewa M. Dzwierzynski, PharmD, BCPS, BCNSP, Pharmacy Site Manager,
The Memorial Hospital of Rhode Island
American Society of Health System Pharmacists (ASHP) Update:
ASHP Policy Issues 2014
Andrea Walsh Haron, PharmD, Clinical Pharmacist Specialist,
Rhode Island Hospital and The Miriam Hospital
Ewa M. Dzwierzynski, PharmD, BCPS, BCNSP, Pharmacy Site Manager,
The Memorial Hospital of Rhode Island
Learning Objectives: Pharmacists
- •• Summarize the ASHP policy making process.
- •• Describe how the ASHP assists with your professional future
- •• State how the Rhode Island Society of Health System Pharmacists (RISHP) delegates should vote on the major issues at the 2014 ASHP House of Delegates sessions.
- •• Identify the major difference between pharmacist provider status and advanced pharmacist practice roles.
- •• Identify the qualifying requirement for pharmacists to claim reimbursement in the proposed legislation, H.R. 4190.
- •• Describe the role of RISHP in furthering provider status in Rhode Island.
- •• Review the legislative process leading to the approval of the Drug Quality and Security Act (H.R. 3204).
- •• Discuss the major provisions of the Drug Quality and Security Act (H.R. 3204).
- •• Identify at least two (2) provisions of the FDA proposed regulations on sterile compounding that ASHP has provided comments for modification or clarification.
Learning Objectives: Technicians
- •• Summarize the ASHP policy making process.
- •• Identify at least one (1) example of ASHP technician advocacy.
- •• State how the Rhode Island Society of Health System Pharmacists (RISHP) delegates should vote on the major issues at the 2014 ASHP House of Delegates sessions.
- •• Describe the major difference between pharmacist provider status and advanced pharmacist practice roles.
- •• Discuss the role of RISHP in furthering provider status in Rhode Island.
- •• Identify at least one (1) lesson learned from the New England Compounding Center (NECC) tragedy of 2012.
- •• Identify at least two (2) elements of the Drug Quality and Safety Act (H.R. 3204) that will help to insure high quality sterile compounded products.
